The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia

 

PDF Download Permissions and Reprints

ABSTRACT

It has been proposed for several decades that infections may be responsible for the accelerated development of atherosclerosis. The initiation of the atherosclerotic plaque is ascribed to focal accumulation of lipids. This explains the importance of plasma lipids in the development of atherosclerosis. Recent reports point towards a possible association between periodontal disease and increased risk for cardiovascular disease. Thus, periodontitis and cardiovascular disease may share common risk factors, and association between periodontitis and coronary heart disease may be due to the elevated levels of plasma lipids. Epidemiological and clinical studies have also suggested that there is a relationship between periodontal disease and impaired lipid metabolism. In this review, we summarized the potential link mechanisms in the association between periodontal infection and serum lipids. (Eur J Dent 2008;2:142-149)

• REFERENCES

• 1 Listgarten MA. Nature of periodontal diseases: Pathogenic mechanisms. J Periodont Res 1987; 22: 172-178
  CrossrefPubMedGoogle Scholar
• 2 Cutler CW, Kamlar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol 1995; 3: 45-51
  CrossrefPubMedGoogle Scholar
• 3 Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL. Association between dental health and acute myocardial infarction. BMJ 1989; 298: 779-781
  CrossrefPubMedGoogle Scholar
• 4 Paquette DW. The periodontal infection-systemic disease link: A review of the truth or myth. J Int Acad Periodontol 2002; 4: 101-109
  PubMedGoogle Scholar
• 5 lacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: Recent concepts involving serum lipids. J Periodontol 2000; 71: 1375-1384
  CrossrefPubMedGoogle Scholar
• 6 Lopes-Virella MF. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 1993; 14: 118-124
  CrossrefPubMedGoogle Scholar
• 7 Samra JS, Summers LKM, Frayn KN. Sepsis and fat metabolism. Br J Surg 1996; 83: 1186-1196
  CrossrefPubMedGoogle Scholar
• 8 Fukushima R, Saito H, Taniwaka K. Different roles of IL-1 and TNF on hemodynamics, amino acid metabolism in dogs. Am J Physiol 1992; 262: 275-281
  Google Scholar
• 9 Van der Poll T, Romijn JA, Endert E, Borm JJ, Buller HR, Sauerwein HP. Tumor necrosis factor mimics the metabolic response to infection in healthy humans. Am J Physiol 1991; 261: 457-465
  Google Scholar
• 10 Gwosdow AR, Kumar MSA, Bode HH. Interleukin-1 stimulation of the hypothalamic-pituitary-adrenal axis. Am J Physiol 1990; 258: 65-70
  Google Scholar
• 11 Imura H, Fukata J, Mori T. Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol 1991; 35: 107-115
  CrossrefPubMedGoogle Scholar
• 12 Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362
  CrossrefPubMedGoogle Scholar
• 13 Feingold KR, Grunfeld C. Tumor necrosis factor alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 1987; 80: 184-190
  CrossrefPubMedGoogle Scholar
• 14 Kurpad A, Khan K, Calder AG. Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue. Am J Physiol 1992; 263: 850-855
  Google Scholar
• 15 Lanza-Jacoby S, Tabares A. Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats. Am J Physiol 1990; 258: 678-685
  Google Scholar
• 16 Fried SK, Zechner R. Tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 1989; 30: 1917-1923
  CrossrefPubMedGoogle Scholar
• 17 Doxey DL, Ng MC, Dill RE, Iacopino AM. Platelet-derived growth factor levels in wounds of diabeticrats. Life Sci 1995; 57:: 1111-23
  CrossrefPubMedGoogle Scholar
• 18 Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM. In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 1999; 296: 331-337
  CrossrefPubMedGoogle Scholar
• 19 Craig TE, Jackson RL, Ohlweiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J Lipid Res 1994; 35: 417-427
  CrossrefPubMedGoogle Scholar
• 20 Van der Poll T, Braxton CC, Coyle SM, Calvano SE, Hack CE, Lowry SF. Effect of hypertriglyceridemia on endotoxin response in humans. Infect Immun 1995; 63: 3396-4000
  CrossrefPubMedGoogle Scholar
• 21 Jovinge S, Ares M, Kallin B, Nilsson J. Human monocytes/ macrophages release TNF-? in response to ox-LDL. Arterioscler Thromb VascBiol 1996; 16: 1573-1579
  Google Scholar
• 22 Dutta-Roy AK. Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 385-399
  CrossrefPubMedGoogle Scholar
• 23 Cabana VG, Siegel JW, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39-49
  CrossrefPubMedGoogle Scholar
• 24 Kerttula Y, Vaara M, Phyhälä L. Effect of bacterial lipopolysaccharide on serum high density lipoprotein cholesterol in rabbits. Atherosclerosis 1984; 52: 123-126
  CrossrefPubMedGoogle Scholar
• 25 Akerlund B, Carlson LA, Jarstrand C. Dyslipoproteinemia in patients with severe bacterial infections. Scand J Infec Dis 1986; 18: 539-545
  CrossrefPubMedGoogle Scholar
• 26 Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32: 142-145
  CrossrefPubMedGoogle Scholar
• 27 Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859-865
  CrossrefPubMedGoogle Scholar
• 28 Van Lenten BJ, Fogelman AM, Seager J, Ribi E, Haberland ME, Edwards PA. Bacterial endotoxin selectively prevents the expression of scavenger receptor activity on human monocyte-macrophages. J Immunol 1985; 134: 3718-3721
  PubMedGoogle Scholar
• 29 Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proce Natl Acad Sci USA 1986; 83: 2704-2708
  CrossrefPubMedGoogle Scholar
• 30 Reidy MA, Bowyer DE. Distortion of endthelial repair The effect of hypercholesterolemia on regeneration of aortic endothelium following injury by endotoxin. Atherosclerosis 1978; 29: 459-466
  CrossrefPubMedGoogle Scholar
• 31 Nam SC, Lee WM, Jarmolych J, Lee KT, Thomas WA. Rapid production of advanced atherosclerosis in swine by a combination of endothelial injury and cholesterol feeding. Exp Mol Pathol 1973; 18: 369-379
  CrossrefPubMedGoogle Scholar
• 32 Yla-Herttuala S. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Med 1991; 23: 561-567
  CrossrefPubMedGoogle Scholar
• 33 Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792
  CrossrefPubMedGoogle Scholar
• 34 Cathcart MK, McNally AK, Morel DW, Chisolm GM. The role of superoxide anion in human monocyte-mediated oxidation and conversion of LDL to a cytotoxin. J Immunol 1988; 142: 1963-1969
  Google Scholar
• 35 Chait A, Han CY, Oram JF, Heinecke JW. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. J Lipid Res 2005; 46: 389-403
  CrossrefPubMedGoogle Scholar
• 36 Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002; 5: 153-158
  CrossrefPubMedGoogle Scholar
• 37 Clamp AG, Ladha S, Clark DC, Grimble RF, Lund EK. The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membrane. Lipids 1997; 32: 179-184
  CrossrefPubMedGoogle Scholar
• 38 Tiwary RK, Clandinin MT, Cinader B. et al. Effect of high polyunsaturated fat diets on the composition of B cell and T cell membrane lipids. Nutr Res 1987; 7: 489-498
  CrossrefGoogle Scholar
• 39 Chapkin TS, Carmichael SL. Effects of dietary n-3 and n-6 polyunsaturated fatty acid on macrophage phospholipids classes and subclasses. Lipids 1990; 25: 827-834
  CrossrefPubMedGoogle Scholar
• 40 Calder PC. Fatty acids, dietary lipids and lymphocyte functions. Biochem Soc Trans 1995; 23: 302-309
  CrossrefPubMedGoogle Scholar
• 41 Endres S, Ghorbani R, Kelley VE. et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271
  CrossrefPubMedGoogle Scholar
• 42 De Pablo MA, Ortega E, Gallego AM, Alvarez C, Pancorbo PL, Alvarez de, Cienfuegos G. The effect of dietary fatty acid manipulation on phagocytic activity and cytokine production by peritoneal cells from Balb/c mice. J Nutr Sci Vitaminol 1998; 44: 57-67
  CrossrefPubMedGoogle Scholar
• 43 Endres S. N-3 polyunsaturated fatty acids and human cytokine synthesis. Lipids 1996; 31: S239-242
  CrossrefPubMedGoogle Scholar
• 44 Robinson DR, Urakaze M, Huang R. et al. Dietary marine lipids suppress continuous expression of interleukin-1β gene expression. Lipids 1996; 31: S23-31
  CrossrefPubMedGoogle Scholar
• 45 De Pablo MA, Ortega E, Gallego AM, Alvarez C, Pancorbo PL, Alvarez de, Cienfuegos G. Influence of diets containing oliveoil sunfloweroil or hydrogenated coconut oil on the immune response of mice. J Clin Biochem Nutr 1998; 25: 11-23
  CrossrefGoogle Scholar
• 46 Yaqoob P, Newsholme EA, Calder PC. Inhibition of natural killer cell activity by dietary lipids. Immunol Lett 1994; 41: 241-247
  CrossrefPubMedGoogle Scholar
• 47 Roder JC, Klein M. Target-effector interaction in the natural killer cell system. J Immunol 1979; 123: 2785-2790
  PubMedGoogle Scholar
• 48 Bray RA, Brahmi Z. Role of lipooxygenation in natural killer cell activation. J Immunol 1986; 136: 1783-1790
  PubMedGoogle Scholar
• 49 Ramstedt U, Ng J, Wigzell H, Serhan CN, Samuelsson B. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity Effects on intracellular cAMP and target cell binding. J Immunol 1985; 135: 3434-3438
  PubMedGoogle Scholar
• 50 Calder PC, Bond JA, Harvey DJ, Gordon S, Newsholme EA. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 1990; 269: 807-814
  CrossrefPubMedGoogle Scholar
• 51 De Pablo MA, De Cienfuegos GA. Modulatory effects of dietary lipids on immune system functions. Immunol Cell Biol 2000; 78: 31-39
  CrossrefPubMedGoogle Scholar
• 52 Uhlinger DJ, Burnham DN, Mullins RE, Kalmar JR, Cutler CW, Arnold RR, Lambeth JD, Merrill Jr AH. Functional differences in human PMNs isolated pre-and post-prendially. FEBS Lett 1991; 286: 28
  CrossrefPubMedGoogle Scholar
• 53 Van Dyke TE, Hosozewicz HV, Cianciola LJ, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun 1980; 27: 124-132
  CrossrefPubMedGoogle Scholar
• 54 Cohen DW, Morris AL. Periodontal manifestations of cyclic neutropenia. J Periodont Res 1961; 32: 159-168
  Google Scholar
• 55 Cutler CW, Wasfy MO, Ghaffar K, Hosni M, Bloyd DR. Impaired bactericidal activity of PMN from two brothers with necrotizing ulcerative gingivo-periodontitis. J Periodontol 1993; 65: 357-363
  Google Scholar
• 56 Croft KD, Beilin LJ, Vandongen R, Rouse I, Masarei J. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. Atherosclerosis 1990; 83: 101-109
  CrossrefPubMedGoogle Scholar
• 57 Krause S, Pohl A, Pohl C, Liebrenz A, Ruhling K, Losche W. Increased generation of reactive oxygen species in mononuclear blood cells from hypercholesterolemic patients. Thromb Res 1993; 71: 237-240
  CrossrefPubMedGoogle Scholar
• 58 Krause S, Brachmann P, Brandes C, Losche W, Hoffmann T, Gangler P. Aggregation behavior of blood granulocytes in patients with periodontal disease. Arch Oral Biol 1990; 35: 75-77
  CrossrefPubMedGoogle Scholar
• 59 Ueno K. Histological studies on the Wistar rats fed cholesterol, sodium cholate and methylthiouracil, with special reference to the changes of the periodontal tissues. Kokubyo Gakkai Zasshi 1965; 32: 368-91
  CrossrefPubMedGoogle Scholar
• 60 Maglakelidze N, Galogre A, Tsagareli Z. Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia. Georgian Med News 2005; 4: 71-74
  Google Scholar
• 61 Ebersole JL, Cappelli D, Mott GE, Kesavalu L, Holt SC, Singer RE. Systemic manifestations of periodontitis in the non-human primate. J Periodont Res 1999; 34: 358-362
  CrossrefPubMedGoogle Scholar
• 62 Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000; 27: 537-541
  CrossrefPubMedGoogle Scholar
• 63 Lösche W, Karapetow F, Pohl A, Krause S, Kocher T. Plasmalipide, blutglucose und PAF-Acetylhydrolase bei marginaler paradontitis. Deutsche Zahnärztliche Zeitschrift 2000; 55: 431-434
  Google Scholar
• 64 Johansson I, Tidehag P, Lundberg V, Hallmans G. Dental status, diet and cardiovascular risk factors in middle-aged people in northern Sweden. Community Dent Oral Epidemiol 1994; 22: 431-436
  CrossrefPubMedGoogle Scholar
• 65 Wakai K, Kawamura T, Umemura O, Hara Y, Machida J, Anno T, Ichihara Y, Mizuno Y, Tamakoshi A, Lin Y, Nakayama T, Ohno Y. Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 1999; 26: 664-672
  CrossrefPubMedGoogle Scholar
• 66 Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 2000; 121: 273-282
  Google Scholar
• 67 Katz J, Chaushu G, Sharabi V. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 2001; 28: 865-868
  CrossrefPubMedGoogle Scholar
• 68 Katz J, Flugelman MY, Golberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 2002; 73: 494-500
  CrossrefPubMedGoogle Scholar
• 69 Buhlin K, Gustafson A, Pockley AG, Frostegard J, Klinge B. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003; 24: 2099-2107
  CrossrefPubMedGoogle Scholar
• 70 Morita M, Horiuchi M, Kinoshita Y, Yamamato T, Watanabe T. Relationship between blood triglyceride levels and periodontal status. Community Dent Health 2004; 21: 32-36
  PubMedGoogle Scholar
• 71 Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim B, Nares S, Iacopino AM. Association between periodontitis and hyperlipidemia: cause or effect?. J Periodontol 1999; 70: 1429-1434
  CrossrefPubMedGoogle Scholar
• 72 Uchiumi D, Kobayashi M, Tachikawa T, Hasegawa K. Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J Periodont Res 2004; 39: 120-128
  CrossrefPubMedGoogle Scholar
• 73 Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, Palosuo T, Alfthan G, Asikainen S. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb VascBiol 2004; 24: 2174-2180
  Google Scholar
• 74 Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, Palosuo T, Alfthan G, Asikainen S. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res 2004; 45: 139-147
  CrossrefPubMedGoogle Scholar
• 75 Lösche W, Marshai GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF. Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 2005; 32: 640-644
  CrossrefPubMedGoogle Scholar
• 76 D’aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84: 269-273
  Google Scholar
• 77 Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol 1999; 70: 1313-1321
  CrossrefPubMedGoogle Scholar
• 78 Noack B, Jachmann I, Roscher S, Sieber L, Kopprasch S, Luck C, Hanefeld M, Hoffmann T. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 2000; 71: 898-903
  CrossrefPubMedGoogle Scholar